EP300 and prostate carcinoma: Degradation of p300/CBP with CBPD-409 abolished H3K27ac as well as the H2BNTac marks in prostate cancer cell lines, without affecting the C-terminal H2BK120ac mark (Figures 3G and S3A–B).